Nucore Health review

What it is

Nucore Health is a physician-owned telehealth platform serving all fifty states, focused on GLP-1 and longevity care. Its live catalogue is compounded semaglutide from $179/month, compounded tirzepatide from $269/month, oral semaglutide from $209/month, NAD⁺ at $149/month any dose, glutathione at $250/month any dose, and MIC B12 and MIC L-carnitine injections, with sermorelin listed but not yet orderable. Clinical infrastructure and pharmacy fulfilment run on OpenLoop Health: you pick a treatment, complete a secure medical intake, and a licensed provider reviews eligibility and prescribes if appropriate.

How it works

Asynchronous and quiz-gated, with a genuinely no-frills commercial structure: no membership fee, no insurance required, FSA/HSA eligible, fast shipping, and no scheduled appointment, meaning the whole flow is intake and review rather than a scheduled appointment. LegitScript certification is displayed with a verification link, the company describes itself as physician-owned, and its own notice states plainly that compounded medications are not FDA-approved and are prescribed off-label by licensed providers. Running care on OpenLoop is a real disclosure too: it means a known, licensed provider network rather than an unnamed one. Two structural weaknesses. The corporate layer is thin — the terms and privacy documents are downloadable files rather than web pages, and no LLC or Inc. legal name appears anywhere on the site. And the catalogue is visibly in transition: the Energy & Anti-Aging category page and the sermorelin product page both display a 'Coming Soon … we're currently transitioning to a new patient platform' panel, while the NAD⁺ and glutathione product pages sitting under that same category are fully priced and have working start buttons. That inconsistency is worth verifying yourself before you plan around any single product.

Pricing transparency

Glutathione is $250 per month at any dose and NAD⁺ is $149 per month at any dose, both stated on their product pages with no membership fee and FSA/HSA eligibility. The 'any dose' phrasing is the part that matters. On this board, a monthly figure is very often an entry tier that rises as a provider titrates you, and several providers say so explicitly in their own terms; a flat rate means the number you read is the number you keep paying. Nucore's GLP-1 line is priced separately at $179, $209 and $269 a month for compounded semaglutide, oral semaglutide and compounded tirzepatide, and none of those is a peptide or NAD⁺ price. Sermorelin has no price because it is not currently orderable. Ask about shipping cadence and cancellation terms at intake, since neither is published on the product pages.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Nucore states this itself — its notice describes compounded medications as not FDA-approved and prescribed off-label by licensed providers — which is a clearer disclosure than several competitors make, though the compounding pharmacy behind OpenLoop's fulfilment is not named on the site, and compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, both live longevity products are weakly supported. Glutathione is the body's principal endogenous antioxidant, and the biology is real, but there is essentially no controlled human outcome trial data behind the detoxification, immune and skin claims made for injected glutathione — the human literature is small and largely cosmetic. NAD⁺ is the same story from a different direction: injected NAD⁺ has no controlled human outcome trials, and the forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit. Sermorelin, when it returns, is a GHRH analogue acting on a real pituitary axis with thin long-term outcome data. Individual results vary.

Pros and watch-outs

The evidence behind what Nucore Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Nucore Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• NUNucific

  Readers weighing NAD⁺ routes who value careful chart disclosure over an upfront price

  See Nucific →
• NKNäky

  NAD⁺ at a rate that does not climb when a provider raises your dose

  See Näky →
• OHObu Health

  NAD⁺ injections from a platform that names the pharmacies preparing them

  See Obu Health →